Semler Scientific, Inc.
SMLR
$18.67
-$1.66-8.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.49M | 8.22M | 8.84M | 12.41M | 13.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.49M | 8.22M | 8.84M | 12.41M | 13.51M |
| Cost of Revenue | 636.00K | 739.00K | 937.00K | 1.10M | 1.16M |
| Gross Profit | 6.86M | 7.48M | 7.90M | 11.31M | 12.36M |
| SG&A Expenses | 11.13M | 8.29M | 7.93M | 6.74M | 6.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.88M | 10.27M | 10.19M | 8.87M | 8.45M |
| Operating Income | -5.39M | -2.05M | -1.35M | 3.54M | 5.07M |
| Income Before Tax | 23.80M | 80.56M | -74.87M | 32.58M | 6.38M |
| Income Tax Expenses | 6.90M | 13.63M | -10.17M | 3.37M | 766.00K |
| Earnings from Continuing Operations | 16.90M | 66.93M | -64.70M | 29.21M | 5.61M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.90M | 66.93M | -64.70M | 29.21M | 5.61M |
| EBIT | -5.39M | -2.05M | -1.35M | 3.54M | 5.07M |
| EBITDA | -5.34M | -2.00M | -1.29M | 3.61M | 5.09M |
| EPS Basic | 1.14 | 5.71 | -6.74 | 3.64 | 0.80 |
| Normalized Basic EPS | 1.00 | 4.29 | -2.87 | 2.53 | 0.57 |
| EPS Diluted | 1.07 | 5.04 | -6.74 | 3.42 | 0.72 |
| Normalized Diluted EPS | 0.90 | 3.73 | -2.87 | 2.38 | 0.51 |
| Average Basic Shares Outstanding | 14.85M | 11.73M | 9.60M | 8.03M | 7.05M |
| Average Diluted Shares Outstanding | 16.55M | 13.48M | 9.60M | 8.57M | 7.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |